SEPN
Septerna Inc.

599
Loading...
Loading...
Septerna, Inc. is a clinical-stage biotechnology company, which engages in pioneering a new era of G protein-coupled receptor oral small molecule drug discovery powered by proprietary Native Complex PlatformTM. Its pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. The company was founded by Robert Joseph Lefkowitz, Arthur Christopoulos, Patrick Sexton, and Jeffrey T. Finer in December 2019 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
75

Frequently Asked Questions

What is Market Cap of Septerna Inc.?
What is the 52-week high for Septerna Inc.?
What is the 52-week low for Septerna Inc.?
What is Septerna Inc. stock price today?
What was Septerna Inc. stock price yesterday?
What is the PE ratio of Septerna Inc.?
What is the Price-to-Book ratio of Septerna Inc.?
What is the 50-day moving average of Septerna Inc.?
How many employess does Septerna Inc. has?

Latest SEPN News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.